Melanoma Trial, Recruiting NCT06685562 Sponsor: Leiden University Medical Center Condition: Melanoma
Back to Melanoma

Melanoma Trial, Recruiting

NCT06685562
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old, either as a patient or as an informal caregiver (such as a family member or friend involved in the care of a patient)
  • People who have been diagnosed with prostate cancer, breast cancer, or melanoma, or who are an informal caregiver for someone with one of these cancers
  • People who are able to give their informed consent to take part in the study
  • People who are able to speak Dutch, Danish, Spanish, or Catalan

Who may not be able to join:

  • People who do not meet all of the above inclusion criteria would not be eligible to participate in this study
  • There are no additional specific exclusion criteria listed beyond not meeting the inclusion criteria above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31(0)715264574

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Leiden University Medical Center
Registry
ClinicalTrials.gov
Start date
20 December 2023
Est. completion
20 May 2026

Where this trial is recruiting

🇩🇰 Denmark 🇳🇱 Netherlands 🇪🇸 Spain

Primary endpoints

The impact of MetroMapping on perceived Shared Decision Making

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov